Trial Profile
Effect of 12 Months Administration of Denosumab in Patients with Rheumatic Diseases
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Rheumatic disorders
- Focus Therapeutic Use
- 04 Feb 2016 New trial record